Recombinant Human Interleukin-2 receptor subunit alpha(IL2RA),partial CSB-EP011649HU2
Specifications
| 20ug / 100ug / 1mg price = 100ug |
Alternative Name(s):
(IL-2 receptor subunit alpha)(IL-2-RA)(IL-2R subunit alpha)(IL2-RA)(TAC antigen)(p55)(CD antigen CD25)
Species: (Organism)
Homo sapiens (Human)
Gene Names:
IL2RA
Tag info:
N-terminal 6xHis-GST-tagged
Target Protein AA Sequence:
ELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQSPMQPVDQASLPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQPQLICT
Expression Region:
22-185aa
Subcellular Location:
Tissue Specificity:
Protein Length:
Partial
Pathway:
Mol. Weight:
50.3 kDa
Purity:
Greater than 85% as determined by SDS-PAGE.
Form:
Liquid or Lyophilized powder
Buffer:
If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Research Areas:
Cancer
Function:
Involvement in disease:
Relevance:
Receptor for interleukin-2. The receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells.
Reconstitution:
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Protein Families:
Reference:
"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity." Goudy K., Aydin D., Barzaghi F., Gambineri E., Vignoli M., Ciullini Mannurita S., Doglioni C., Ponzoni M., Cicalese M.P., Assanelli A., Tommasini A., Brigida I., Dellepiane R.M., Martino S., Olek S., Aiuti A., Ciceri F., Roncarolo M.G., Bacchetta R. Clin. Immunol. 146:248-261(2013)
